Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2015

01.02.2015 | Clinical Trial

Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer

verfasst von: Yu Feng, Rui Huang, Yingjian He, Aiping Lu, Zhaoqing Fan, Tie Fan, Meng Qi, Xinguang Wang, Wei Cao, Xing Wang, Yuntao Xie, Tianfeng Wang, Jinfeng Li, Tao Ouyang

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to compare the efficacy of physical examination (PE), ultrasound (US), and US combined with fine-needle cytology (US-FNAC) in evaluation of node status before sentinel lymph node biopsy (SLNB) for breast cancer patients. We performed a retrospective study of 3,781 breast cancer patients and calculated the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for PE, US, and US-FNAC, respectively. A total of 3,175 cases were documented as cN0 and 606 as cN1. Abnormal axillary nodes under US were detected in 1,152 cases, among which 821 were proven to have positive nodes by FNAC. The positive FNAC results enabled 11.7 % of cN0 patients (373/3,175) to avoid unnecessary SLNB. All 331 cases with abnormal US but negative FNAC results, and the 2,629 cases with normal US underwent SLNB procedure for nodal staging, and metastatic nodes were identified in 745 patients. The sensitivity of PE was 32.2 %, with a specificity of 95.5 %, a PPV of 83.5 %, a NPV of 65 %, and an accuracy of 69.3 %. The sensitivity, specificity, PPV, NPV, and accuracy of axillary US alone were 58.6, 89.4, 79.6, 75.3, and 76.7 %, respectively. Combining axillary US with FNAC resulted in sensitivity, specificity, PPV, NPV, and accuracy of 52.4, 100, 100, 74.8, and 80.3 %, respectively. Our study demonstrated that US-FNAC is a feasible and effective triage during axillary staging for newly diagnosed breast cancer patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98(9):599–609CrossRefPubMed Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98(9):599–609CrossRefPubMed
2.
Zurück zum Zitat Sacre RA (1986) Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12(2):169–173PubMed Sacre RA (1986) Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12(2):169–173PubMed
3.
Zurück zum Zitat Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, Holmes DR, Sposto R, Sener SF (2012) Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol 19(6):1825–1830CrossRefPubMed Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, Holmes DR, Sposto R, Sener SF (2012) Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol 19(6):1825–1830CrossRefPubMed
4.
Zurück zum Zitat Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol 186(5):1342–1348CrossRef Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J (2006) Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol 186(5):1342–1348CrossRef
5.
Zurück zum Zitat Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes Olmos R, Schultze Kool LJ (2003) Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39(8):1068–1073CrossRefPubMed Deurloo EE, Tanis PJ, Gilhuijs KG, Muller SH, Kroger R, Peterse JL, Rutgers EJ, Valdes Olmos R, Schultze Kool LJ (2003) Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 39(8):1068–1073CrossRefPubMed
6.
Zurück zum Zitat Damera A, Evans AJ, Cornford EJ, Wilson AR, Burrell HC, James JJ, Pinder SE, Ellis IO, Lee AH, Macmillan RD (2003) Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer 89(7):1310–1313CrossRefPubMedCentralPubMed Damera A, Evans AJ, Cornford EJ, Wilson AR, Burrell HC, James JJ, Pinder SE, Ellis IO, Lee AH, Macmillan RD (2003) Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer. Br J Cancer 89(7):1310–1313CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Ciatto S, Brancato B, Risso G, Ambrogetti D, Bulgaresi P, Maddau C, Turco P, Houssami N (2007) Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat 103(1):85–91CrossRefPubMed Ciatto S, Brancato B, Risso G, Ambrogetti D, Bulgaresi P, Maddau C, Turco P, Houssami N (2007) Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat 103(1):85–91CrossRefPubMed
8.
Zurück zum Zitat Genta F, Zanon E, Camanni M, Deltetto F, Drogo M, Gallo R, Gilardi C (2007) Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 31(6):1155–1163CrossRefPubMed Genta F, Zanon E, Camanni M, Deltetto F, Drogo M, Gallo R, Gilardi C (2007) Cost/accuracy ratio analysis in breast cancer patients undergoing ultrasound-guided fine-needle aspiration cytology, sentinel node biopsy, and frozen section of node. World J Surg 31(6):1155–1163CrossRefPubMed
9.
Zurück zum Zitat Sapino A, Cassoni P, Zanon E, Fraire F, Croce S, Coluccia C, Donadio M, Bussolati G (2003) Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 88(5):702–706CrossRefPubMedCentralPubMed Sapino A, Cassoni P, Zanon E, Fraire F, Croce S, Coluccia C, Donadio M, Bussolati G (2003) Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 88(5):702–706CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK (2002) Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5):982–988CrossRefPubMed Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK (2002) Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5):982–988CrossRefPubMed
11.
Zurück zum Zitat Wang XJ, Lin BH, Yang Z, Ouyang T, Li JF, Xu B, Zhang Y, Zhang MY (2006) Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient. Zhonghua Zhong Liu Za Zhi 28(3):200–203PubMed Wang XJ, Lin BH, Yang Z, Ouyang T, Li JF, Xu B, Zhang Y, Zhang MY (2006) Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient. Zhonghua Zhong Liu Za Zhi 28(3):200–203PubMed
12.
Zurück zum Zitat Li JF, Ouyang T, Wang XJ, Wang TF, Xie YT, Fan ZQ, Lin BH, Yang Z, Lin BY (2006) Preliminary study of new imaging agent, 99mTc-Rituximab, for sentinel lymph node biopsy of primary breast cancer. Zhonghua Wai Ke Za Zhi 44(9):600–602PubMed Li JF, Ouyang T, Wang XJ, Wang TF, Xie YT, Fan ZQ, Lin BH, Yang Z, Lin BY (2006) Preliminary study of new imaging agent, 99mTc-Rituximab, for sentinel lymph node biopsy of primary breast cancer. Zhonghua Wai Ke Za Zhi 44(9):600–602PubMed
13.
Zurück zum Zitat Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720CrossRefPubMed Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703–7720CrossRefPubMed
14.
Zurück zum Zitat Wells B, Saskin R, Wright F, McCready D, Quan ML (2013) Measuring the quality of sentinel lymph node biopsy (SLNB) for breast cancer: a population-based evaluation. Ann Surg Oncol 20(2):615–619CrossRefPubMed Wells B, Saskin R, Wright F, McCready D, Quan ML (2013) Measuring the quality of sentinel lymph node biopsy (SLNB) for breast cancer: a population-based evaluation. Ann Surg Oncol 20(2):615–619CrossRefPubMed
15.
Zurück zum Zitat Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251(4):595–600CrossRefPubMed Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251(4):595–600CrossRefPubMed
16.
Zurück zum Zitat Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933CrossRefPubMedCentralPubMed Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat Majid S, Tengrup I, Manjer J (2013) Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women. World J Surg 37(1):67–71CrossRefPubMed Majid S, Tengrup I, Manjer J (2013) Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women. World J Surg 37(1):67–71CrossRefPubMed
18.
Zurück zum Zitat Pamilo M, Soiva M, Lavast EM (1989) Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 8(3):115–120PubMed Pamilo M, Soiva M, Lavast EM (1989) Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 8(3):115–120PubMed
19.
Zurück zum Zitat Lam WW, Yang WT, Chan YL, Stewart IE, Metreweli C, King W (1996) Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 23(5):498–503CrossRefPubMed Lam WW, Yang WT, Chan YL, Stewart IE, Metreweli C, King W (1996) Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography. Eur J Nucl Med 23(5):498–503CrossRefPubMed
20.
Zurück zum Zitat Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C (1996) High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 15(3):241–246PubMed Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C (1996) High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 15(3):241–246PubMed
21.
Zurück zum Zitat Yang WT, Metreweli C (1998) Colour Doppler flow in normal axillary lymph nodes. Br J Radiol 71(844):381–383CrossRefPubMed Yang WT, Metreweli C (1998) Colour Doppler flow in normal axillary lymph nodes. Br J Radiol 71(844):381–383CrossRefPubMed
22.
Zurück zum Zitat Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F et al (2003) Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10(9):1025–1030CrossRefPubMed Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F et al (2003) Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10(9):1025–1030CrossRefPubMed
23.
Zurück zum Zitat Garcia Fernandez A, Fraile M, Gimenez N, Rene A, Torras M, Canales L, Torres J, Barco I, Gonzalez S, Veloso E et al (2011) Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy. Ultrasound Med Biol 37(1):16–22CrossRefPubMed Garcia Fernandez A, Fraile M, Gimenez N, Rene A, Torras M, Canales L, Torres J, Barco I, Gonzalez S, Veloso E et al (2011) Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy. Ultrasound Med Biol 37(1):16–22CrossRefPubMed
24.
Zurück zum Zitat Park SH, Kim MJ, Park BW, Moon HJ, Kwak JY, Kim EK (2011) Impact of preoperative ultrasonography and fine-needle aspiration of axillary lymph nodes on surgical management of primary breast cancer. Ann Surg Oncol 18(3):738–744CrossRefPubMed Park SH, Kim MJ, Park BW, Moon HJ, Kwak JY, Kim EK (2011) Impact of preoperative ultrasonography and fine-needle aspiration of axillary lymph nodes on surgical management of primary breast cancer. Ann Surg Oncol 18(3):738–744CrossRefPubMed
25.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7(12):983–990CrossRefPubMed Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7(12):983–990CrossRefPubMed
26.
Zurück zum Zitat Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106(1):4–16CrossRefPubMed Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106(1):4–16CrossRefPubMed
27.
Zurück zum Zitat Leenders M, Richir M, Broeders M, Moormann G, Mollema R, Lopes Cardozo A, Meijer S, Schreurs H (2013) Axillary staging by ultrasound-guided fine-needle aspiration cytology in breast cancer patients. Still up to date? Breast J 19(6):637–642CrossRefPubMed Leenders M, Richir M, Broeders M, Moormann G, Mollema R, Lopes Cardozo A, Meijer S, Schreurs H (2013) Axillary staging by ultrasound-guided fine-needle aspiration cytology in breast cancer patients. Still up to date? Breast J 19(6):637–642CrossRefPubMed
28.
Zurück zum Zitat Houssami N, Ciatto S, Turner RM, Cody HS 3rd (2011) Macaskill P: Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254(2):243–251CrossRefPubMed Houssami N, Ciatto S, Turner RM, Cody HS 3rd (2011) Macaskill P: Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg 254(2):243–251CrossRefPubMed
29.
Zurück zum Zitat Yuan XM, Wang N, Ouyang T, Yang L, Song MY, Lin BY, Xie YT, Li JF, Pan KF, You WC et al (2011) Current status of diagnosis and treatment of primary breast cancer in Beijing, 2008. Chin J Cancer Res 23(1):38–42CrossRefPubMedCentralPubMed Yuan XM, Wang N, Ouyang T, Yang L, Song MY, Lin BY, Xie YT, Li JF, Pan KF, You WC et al (2011) Current status of diagnosis and treatment of primary breast cancer in Beijing, 2008. Chin J Cancer Res 23(1):38–42CrossRefPubMedCentralPubMed
Metadaten
Titel
Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer
verfasst von
Yu Feng
Rui Huang
Yingjian He
Aiping Lu
Zhaoqing Fan
Tie Fan
Meng Qi
Xinguang Wang
Wei Cao
Xing Wang
Yuntao Xie
Tianfeng Wang
Jinfeng Li
Tao Ouyang
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2015
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3280-z

Weitere Artikel der Ausgabe 3/2015

Breast Cancer Research and Treatment 3/2015 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.